These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human-Induced Pluripotent Stem Cell‒Derived Keratinocytes, a Useful Model to Identify and Explore the Pathological Phenotype of Epidermolysis Bullosa Simplex. Coutier J; Bonnette M; Martineau S; Mercadier A; Domingues S; Saidani M; Jarrige M; Polveche H; Darle A; Holic N; Hadj-Rabia S; Bodemer C; Lemaitre G; Martinat C; Baldeschi C J Invest Dermatol; 2022 Oct; 142(10):2695-2705.e11. PubMed ID: 35490743 [TBL] [Abstract][Full Text] [Related]
4. Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex. Evtushenko NA; Beilin AK; Kosykh AV; Vorotelyak EA; Gurskaya NG Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830328 [TBL] [Abstract][Full Text] [Related]
5. Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness. Homberg M; Ramms L; Schwarz N; Dreissen G; Leube RE; Merkel R; Hoffmann B; Magin TM J Invest Dermatol; 2015 Oct; 135(10):2437-2445. PubMed ID: 25961909 [TBL] [Abstract][Full Text] [Related]
6. Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition. Chamcheu JC; Lorié EP; Akgul B; Bannbers E; Virtanen M; Gammon L; Moustakas A; Navsaria H; Vahlquist A; Törmä H J Dermatol Sci; 2009 Mar; 53(3):198-206. PubMed ID: 19157792 [TBL] [Abstract][Full Text] [Related]
7. A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplex. Tan TS; Common JEA; Lim JSY; Badowski C; Firdaus MJ; Leonardi SS; Lane EB J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34643242 [TBL] [Abstract][Full Text] [Related]
8. Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. Rugg EL; Horn HM; Smith FJ; Wilson NJ; Hill AJ; Magee GJ; Shemanko CS; Baty DU; Tidman MJ; Lane EB J Invest Dermatol; 2007 Mar; 127(3):574-80. PubMed ID: 17039244 [TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Morley SM; D'Alessandro M; Sexton C; Rugg EL; Navsaria H; Shemanko CS; Huber M; Hohl D; Heagerty AI; Leigh IM; Lane EB Br J Dermatol; 2003 Jul; 149(1):46-58. PubMed ID: 12890194 [TBL] [Abstract][Full Text] [Related]
10. In silico analysis of all point mutations on the 2B domain of K5/K14 causing epidermolysis bullosa simplex: a genotype-phenotype correlation. Banerjee S; Wu Q; Yu P; Qi M; Li C Mol Biosyst; 2014 Oct; 10(10):2567-77. PubMed ID: 25017986 [TBL] [Abstract][Full Text] [Related]
11. Functional testing of keratin 14 mutant proteins associated with the three major subtypes of epidermolysis bullosa simplex. Sørensen CB; Andresen BS; Jensen UB; Jensen TG; Jensen PK; Gregersen N; Bolund L Exp Dermatol; 2003 Aug; 12(4):472-9. PubMed ID: 12930305 [TBL] [Abstract][Full Text] [Related]
12. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Bolling MC; Lemmink HH; Jansen GH; Jonkman MF Br J Dermatol; 2011 Mar; 164(3):637-44. PubMed ID: 21375516 [TBL] [Abstract][Full Text] [Related]
13. Keratin gene mutations influence the keratinocyte response to DNA damage and cytokine induced apoptosis. Zupancic T; Sersa G; Törmä H; Lane EB; Herrmann H; Komel R; Liovic M Arch Dermatol Res; 2017 Sep; 309(7):587-593. PubMed ID: 28647894 [TBL] [Abstract][Full Text] [Related]
14. ERK involvement in resistance to apoptosis in keratinocytes with mutant keratin. Russell D; Ross H; Lane EB J Invest Dermatol; 2010 Mar; 130(3):671-81. PubMed ID: 19847192 [TBL] [Abstract][Full Text] [Related]
15. Cytokines as genetic modifiers in K5-/- mice and in human epidermolysis bullosa simplex. Roth W; Reuter U; Wohlenberg C; Bruckner-Tuderman L; Magin TM Hum Mutat; 2009 May; 30(5):832-41. PubMed ID: 19267394 [TBL] [Abstract][Full Text] [Related]
16. Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives. Bchetnia M; Powell J; McCuaig C; Boucher-Lafleur AM; Morin C; Dupéré A; Laprise C Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273442 [TBL] [Abstract][Full Text] [Related]
17. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients. Morley SM; Dundas SR; James JL; Gupta T; Brown RA; Sexton CJ; Navsaria HA; Leigh IM; Lane EB J Cell Sci; 1995 Nov; 108 ( Pt 11)():3463-71. PubMed ID: 8586658 [TBL] [Abstract][Full Text] [Related]
18. Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability. Sawant M; Schwarz N; Windoffer R; Magin TM; Krieger J; Mücke N; Obara B; Jankowski V; Jankowski J; Wally V; Lettner T; Leube RE J Invest Dermatol; 2018 Mar; 138(3):627-636. PubMed ID: 29080682 [TBL] [Abstract][Full Text] [Related]
20. A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Chan Y; Anton-Lamprecht I; Yu QC; Jäckel A; Zabel B; Ernst JP; Fuchs E Genes Dev; 1994 Nov; 8(21):2574-87. PubMed ID: 7525408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]